financetom
EMR
financetom
/
Industrials
/
EMR
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Emerson Electric Co.EMR
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Emerson Electric Co., a technology and software company, provides various solutions for customers in industrial, commercial, and consumer markets in the Americas, Asia, the Middle East, Africa, and Europe.

It operates in six segments: Final Control, Control Systems & Software, Measurement & Analytical, AspenTech, Discrete Automation, and Safety & Productivity.

The Final Control segment provides control, isolation, shutoff, pressure relief, and pressure safety valves, actuators, and regulators for process and hybrid industries.

The Measurement & Analytical segment offers intelligent instrumentation measuring the physical properties of liquids or gases, such as pressure, temperature, level, flow, acoustics, corrosion, pH, conductivity, water quality, toxic gases, and flame.

The Discrete Automation segment offers solenoid and pneumatic valves, valve position indicators, pneumatic cylinders, air preparation equipment, pressure and temperature switches, electric linear motion solutions, programmable automation control systems, electrical distribution equipment, and materials joining solutions.

The Safety & Productivity segment offers tools for professionals and homeowners; pipe-working tools, including pipe wrenches, pipe cutters, pipe threading and roll grooving equipment, battery hydraulic tools; electrical tools; and other professional tools.

The Control Systems & Software segment provides distributed control systems, safety instrumented systems, SCADA systems, application software, digital twins, asset performance management, and cybersecurity.

The Test & Measurement provides software-connected automated test and measurement systems. The AspenTech segment provides asset optimization software that enables industrial manufacturers to design, operate, and maintain operations for enhancing performance through a combination of decades of modeling, simulation, and optimization capabilities.

The company was incorporated in 1890 and is headquartered in Saint Louis, Missouri.

Latest News >
Bank of America to open more than 150 new branches by 2027
Bank of America to open more than 150 new branches by 2027
May 26, 2025
May 13 (Reuters) - Bank of America ( BAC ) plans to open more than 150 new branches by the end of 2027, it said on Tuesday, as part of the lender's efforts to expand its physical presence across the United States. The bank will open 40 new branches this year, with an additional 70 sites planned for 2026, it...
GM, LG to make new, lower-cost cells for future EVs
GM, LG to make new, lower-cost cells for future EVs
May 26, 2025
DETROIT (Reuters) -General Motors ( GM ) and battery partner LG Energy Solution are planning to start commercial production of lower-cost cells for future electric vehicles at a U.S. facility starting in 2028, the companies said on Tuesday.  The cells will have a lithium manganese-rich (LMR) chemistry, which GM says is lower cost than the nickel-rich cells used today, but...
OMS Energy Technologies Prices 3.7 Million Share IPO at $9 per Share
OMS Energy Technologies Prices 3.7 Million Share IPO at $9 per Share
May 26, 2025
10:05 AM EDT, 05/13/2025 (MT Newswires) -- OMS Energy Technologies ( OMSE ) said Tuesday it priced its initial public offering of about 3.7 million ordinary shares at $9 per share. The total base offering size is $33.3 million, assuming the underwriters don't exercise their 45-day option to buy up to 555,555 additional ordinary shares at the IPO price, the...
Bright Minds Biosciences Says BMB-101 Eliminated Drop Attacks in Mouse Model of Epilepsy
Bright Minds Biosciences Says BMB-101 Eliminated Drop Attacks in Mouse Model of Epilepsy
May 26, 2025
10:03 AM EDT, 05/13/2025 (MT Newswires) -- Bright Minds Biosciences ( DRUG ) said Tuesday that its BMB-101 showed a complete elimination of drop attacks in the DBA/2 mouse model of epilepsy. Notably, BMB-101 achieved 100% survival in the DBA/2 model, reversing brainstem serotonin deficits and preventing seizure-induced respiratory arrest, Jan Torleif Pedersen, the company's chief science officer, said. The...
Copyright 2023-2026 - www.financetom.com All Rights Reserved